{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:23:57Z","timestamp":1790126637336,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methylmalonic acidemia (MMA) is a rare autosomal recessive inborn error of metabolism commonly presenting in infancy with episodes of metabolic acidosis that can lead to considerable morbidity and early mortality. Oxidative stress is a major aspect in the pathogenesis of MMA. We aimed to evaluate the clinical utility of fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) and correlate their levels with established biomarkers of oxidative stress, such as reduced glutathione (GSH) and reduced\/oxidized (GSH\/GSSG) glutathione ratio in MMA children in a clinical setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Nineteen MMA pediatric patients (median 5.7; IOR 2.9\u20137.3 years) were recruited. Thirty age and sex matched healthy children were further recruited as a comparator group. Total glutathione, reduced glutathione, FGF21 and GDF15 were assayed for both cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Total and reduced glutathione were significantly reduced in MMA patients compared to controls (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 for both), while FGF21 and GDF15 were significantly elevated (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.037 and &lt;\u20090.001, respectively). Both FGF21 and GDF15 had a significant negative correlation with GSH\/GSSG ratio (\n                      <jats:italic>r<\/jats:italic>\n                      =\u20130.256;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.038 and\n                      <jats:italic>r<\/jats:italic>\n                      =\u20130.367;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005, respectively); however, only GDF15 had a negative correlation with both total and reduced glutathione (\n                      <jats:italic>r<\/jats:italic>\n                      =\u20130.443;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 and\n                      <jats:italic>r<\/jats:italic>\n                      =\u20130.459;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). GDF15 had a better performance in the ROC curve analysis; AUC\u2009=\u20090.805 vs. 0.668 for FGF21, while FGF21 was a significant predictor of eGFR in the linear regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FGF21 and GDF15 were both significantly increased in the studied MMA pediatric patients and had strong correlations with established oxidative stress biomarkers. Since both are more stable during storage and easier to assay than glutathione based indicators, their use as candidate biomarkers for oxidative stress in MMA children can be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06719-4","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:40:38Z","timestamp":1774593638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fibroblast growth factor 21 and growth differentiation factor 15 as biomarkers for oxidative stress in children with methylmalonic acidemia"],"prefix":"10.1186","volume":"26","author":[{"given":"Maha A.","family":"Abd Elbaky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Abdelkhalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian Y.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3154-1948","authenticated-orcid":false,"given":"Mohamed A.","family":"Elmonem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"2","key":"6719_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5582\/irdr.2018.01026","volume":"7","author":"X Zhou","year":"2018","unstructured":"Zhou X, Cui Y, Han J. Methylmalonic acidemia: Current status and research priorities. Intract Rare Dis Res. 2018;7(2):73\u20138. https:\/\/doi.org\/10.5582\/irdr.2018.01026.","journal-title":"Intract Rare Dis Res"},{"key":"6719_CR2","doi-asserted-by":"publisher","first-page":"1110942","DOI":"10.3389\/fnins.2023.1110942","volume":"17","author":"T Chen","year":"2023","unstructured":"Chen T, Gao Y, Zhang S, Wang Y, Sui C, Yang L. Methylmalonic acidemia: Neurodevelopment and neuroimaging. Front Neurosci. 2023;17:1110942. https:\/\/doi.org\/10.3389\/fnins.2023.1110942.","journal-title":"Front Neurosci"},{"issue":"1","key":"6719_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43066-022-00176-1","volume":"12","author":"S Abdelsattar","year":"2022","unstructured":"Abdelsattar S, Obada M, El-Hawy MA, Abd El Naby SA, Zaki OK, Elsaid H. Inherited metabolic disorders in a cohort of Egyptian children. Egypt Liver J. 2022;12(1):20. https:\/\/doi.org\/10.1186\/s43066-022-00176-1.","journal-title":"Egypt Liver J"},{"issue":"9","key":"6719_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.clinbiochem.2014.04.002","volume":"47","author":"LA Selim","year":"2014","unstructured":"Selim LA, Hassan SAH, Salem F, Orabi A, Hassan FA, El-Mougy F, Mahmoud IG, El-Badawy A, Girgis MY, Elmonem MA, Mehaney D. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children: a 5 year report. Clin Biochem. 2014;47(9):823\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.04.002.","journal-title":"Clin Biochem"},{"issue":"3","key":"6719_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/0969141315618229","volume":"23","author":"FA Hassan","year":"2016","unstructured":"Hassan FA, El-Mougy F, Sharaf SA, Mandour I, Morgan MF, Selim LA, Hassan SA, Salem F, Oraby A, Girgis MY, Mahmoud IG, El-Badawy A, El-Nekhely I, Moharam N, Mehaney DA. &Elmonem, M.A. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study. J Med Screen. 2016;23(3):124\u20139. https:\/\/doi.org\/10.1177\/0969141315618229.","journal-title":"J Med Screen"},{"key":"6719_CR6","doi-asserted-by":"crossref","unstructured":"Lo SF. Organic acid disorders. In: Garg U, Smith LD, editors. Biomarkers in Inborn Errors of Metabolism. San Diego: Elsevier; 2017. pp. 65\u201385.","DOI":"10.1016\/B978-0-12-802896-4.00002-X"},{"issue":"3","key":"6719_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jimd.12370(","volume":"44","author":"P Forny","year":"2021","unstructured":"Forny P, H\u00f6rster F, Ballhausen D, Chakrapani A, Chapman KA, Dionisi-Vici C, Dixon M, Gr\u00fcnert SC, Grunewald S, Haliloglu G, Hochuli M, Honzik T, Karall D, Martinelli D, Molema F, Sass JO, Scholl-B\u00fcrgi S, Tal G, Williams M, Huemer M, Baumgartner MR. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision. J Inherit Metab Dis. 2021;44(3):566\u201392. https:\/\/doi.org\/10.1002\/jimd.12370(.","journal-title":"J Inherit Metab Dis"},{"issue":"19","key":"6719_CR8","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3390\/cells11193179","volume":"11","author":"SA Keller","year":"2022","unstructured":"Keller SA, Luciani A. Mitochondrial distress in methylmalonic acidemia: novel pathogenic insights and therapeutic perspectives. Cells. 2022;11(19):3179. https:\/\/doi.org\/10.3390\/cells11193179.","journal-title":"Cells"},{"issue":"3","key":"6719_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","volume":"3","author":"A Kharitonenkov","year":"2014","unstructured":"Kharitonenkov A, Adams AC. Inventing new medicines: the FGF21 story. Mol Metab. 2014;3(3):221\u20139. https:\/\/doi.org\/10.1016\/j.molmet.2013.12.003.","journal-title":"Mol Metab"},{"issue":"4","key":"6719_CR10","doi-asserted-by":"publisher","first-page":"e174097","DOI":"10.1172\/jci.insight.174097","volume":"9","author":"I Manoli","year":"2024","unstructured":"Manoli I, Sysol JR, Head PE, Epping MW, Gavrilova O, Crocker MK, Sloan JL, Koutsoukos SA, Wang C, Ktena YP, Mendelson S, Pass AR, Zerfas PM, Hoffmann V, Vernon HJ, Fletcher LA, Reynolds JC, Tsokos MG, Stratakis CA, Voss SD, Chen KY, Brown RJ, Hamosh A, Berry GT, Chen XS, Yanovski JA, Venditti CP. Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation. JCI Insight. 2024;9(4):e174097. https:\/\/doi.org\/10.1172\/jci.insight.174097.","journal-title":"JCI Insight"},{"issue":"9","key":"6719_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen A, Elo JM, Pietil\u00e4inen KH, Hakonen AH, Sevastianova K, Korpela M, Isohanni P, Marjavaara SK, Tyni T, Kiuru-Enari S, Pihko H, Darin N, \u00d5unap K, Kluijtmans LAJ, Paetau A, Buzkova J, Bindoff LA, Annunen-Rasila J, Uusimaa J, Rissanen A, Yki-J\u00e4rvinen H, Hirano M, Tulinius M, Smeitink J. &Tyynismaa, H. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 2011;10(9):806\u201318. https:\/\/doi.org\/10.1016\/S1474-4422(11)70155-7.","journal-title":"Lancet Neurol"},{"issue":"6","key":"6719_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/jimd.12287","volume":"43","author":"E Maines","year":"2020","unstructured":"Maines E, Catesini G, Boenzi S, Mosca A, Candusso M, Dello Strologo L, Martinelli D, Maiorana A, Liguori A, Olivieri G, Taurisano R, Piemonte F, Rizzo C, Spada M, Dionisi-Vici C. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia. J Inherit Metab Dis. 2020;43(6):1173\u201385. https:\/\/doi.org\/10.1002\/jimd.12287.","journal-title":"J Inherit Metab Dis"},{"issue":"23","key":"6719_CR13","doi-asserted-by":"publisher","first-page":"e124351","DOI":"10.1172\/jci.insight.124351","volume":"3","author":"I Manoli","year":"2018","unstructured":"Manoli I, Sysol JR, Epping MW, Li L, Wang C, Sloan JL, Pass A, Gagn\u00e9 J, Ktena YP, Li L, Trivedi NS, Ouattara B, Zerfas PM, Hoffmann V, Abu-Asab M, Tsokos MG, Kleiner DE, Garone C, Cusmano-Ozog K, Enns GM, Vernon HJ, Andersson HC, Grunewald S, Elkahloun AG, Girard CL, Schnermann J, DiMauro S, Andres-Mateos E, Vandenberghe LH, Chandler RJ, Venditti CP. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia. JCI Insight. 2018;3(23):e124351. https:\/\/doi.org\/10.1172\/jci.insight.124351.","journal-title":"JCI Insight"},{"issue":"2","key":"6719_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/ijo.2015.242","volume":"40","author":"VWW Tsai","year":"2016","unstructured":"Tsai VWW, Lin S, Brown DA, Salis A, Breit SN. Anorexia\u2013cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1\/GDF15. Int J Obes (Lond). 2016;40(2):193\u20137. https:\/\/doi.org\/10.1038\/ijo.2015.242.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"6719_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel S, Alvarez-Guaita A, Melvin A, Rimmington D, Dattilo A, Miedzybrodzka EL, Cimino I, Maurin AC, Roberts GP, Meek CL, Virtue S, Sparks LM, Parsons SA, Redman LM, Bray GA, Liou AP, Woods RM, Parry SA, Jeppesen PB, Kolnes AJ, Harding HP, Ron D, Vidal-Puig A, Reimann F, Gribble FM, Hulston CJ, Farooqi IS, Fafournoux P, Smith SR, Jensen J, Breen D, Wu Z, Zhang BB, Coll AP, Savage DB. O\u2019rahilly, S. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 2019;29(3):707\u201318. https:\/\/doi.org\/10.1016\/j.cmet.2018.12.016. DOI DOI.","journal-title":"Cell Metab"},{"issue":"10","key":"6719_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang D, Day EA, Townsend LK, Djordjevic D, J\u00f8rgensen SB, Steinberg GR. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol. 2021;17(10):592\u2013607. https:\/\/doi.org\/10.1038\/s41574-021-00529-7.","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"6719_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.clinbiochem.2014.04.002","volume":"47","author":"LA Selim","year":"2014","unstructured":"Selim LA, Hassan SA, Salem F, Orabi A, Hassan FA, El-Mougy F, Mahmoud IG, El-Badawy A, Girgis MY, Elmonem MA, Mehaney D. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children: a 5 year report. Clin Biochem. 2014;47(9):823\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.04.002.","journal-title":"Clin Biochem"},{"issue":"1","key":"6719_CR18","doi-asserted-by":"publisher","first-page":"e15469","DOI":"10.1111\/ped.15469","volume":"65","author":"DA Mehaney","year":"2023","unstructured":"Mehaney DA, Seliem ZS, Selim LA, Khalil MS, Abou-Youssef HS, Elsayed EM, Abdou DM, Rizzo C, Dioniasi-Vici C, Abdelazim AM, Elkady SH. Organic acidurias in Egyptian children: The urge for high-risk screening. Pediatr Int. 2023;65(1):e15469. https:\/\/doi.org\/10.1111\/ped.15469.","journal-title":"Pediatr Int"},{"key":"6719_CR19","doi-asserted-by":"publisher","unstructured":"Liu Y, Wang S, Zhang X, Cai H, Liu J, Fang S, Yu B. The regulation and characterization of mitochondrial-derived methylmalonic acid in mitochondrial dysfunction and oxidative stress: from basic research to clinical practice. Oxid Med Cell Longev. 2022;2022(7043883). https:\/\/doi.org\/10.1155\/2022\/7043883.","DOI":"10.1155\/2022\/7043883"},{"issue":"1","key":"6719_CR20","doi-asserted-by":"publisher","first-page":"7653716","DOI":"10.1155\/2020\/7653716","volume":"2020","author":"A Mobarak","year":"2020","unstructured":"Mobarak A, Dawoud H, Mokhtar WA, Sadek AA, Bebars GM, Othman AA, Magdy RM, Nofal N. &Zoair, A. Propionic and methylmalonic acidemias: initial clinical and biochemical presentation. Int J Pediatr. 2020;2020(1):7653716. https:\/\/doi.org\/10.1155\/2020\/7653716.","journal-title":"Int J Pediatr"},{"issue":"2","key":"6719_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.21608\/cupsj.2023.218859.1098","volume":"3","author":"MF Ibrahim","year":"2023","unstructured":"Ibrahim MF, Girgis MY, Nassar SI, Seif HM, Kamel SM, Kamel MA. Brain Magnetic Resonance Imaging in Organic Acidemias: A Single Center Experience. Pediatr Sci J. 2023;3(2):72\u201380. https:\/\/doi.org\/10.21608\/cupsj.2023.218859.1098.","journal-title":"Pediatr Sci J"},{"key":"6719_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s44162-025-00118-6","volume":"4","author":"ZS Abdelkhalek","year":"2025","unstructured":"Abdelkhalek ZS, Abdelbaky MA, Elmonem MA. The metabolomics of organic acidemias: current advances and future prospects. J Rare Dis. 2025;4:54. https:\/\/doi.org\/10.1007\/s44162-025-00118-6.","journal-title":"J Rare Dis"},{"issue":"1","key":"6719_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev-genom-083118-014954","volume":"20","author":"L Romdhane","year":"2019","unstructured":"Romdhane L, Mezzi N, Hamdi Y, El-Kamah G, Barakat A, Abdelhak S. Consanguinity and inbreeding in health and disease in North African populations. Annu Rev Genomics Hum Genet. 2019;20(1):155\u201379. https:\/\/doi.org\/10.1146\/annurev-genom-083118-014954.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"6719_CR24","first-page":"74","volume":"10","author":"R Najafi","year":"2016","unstructured":"Najafi R, Hashemipour M, Mostofizadeh N, Ghazavi M, Nasiri J, Shahsanai A, Famori F, Najafi F&, Moafi M. Demographic and clinical findings in pediatric patients affected by organic acidemia. Iran J Child Neurol. 2016;10(2):74.","journal-title":"Iran J Child Neurol"},{"issue":"1","key":"6719_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5339\/qmj.2015.9","volume":"2015","author":"HK Shennar","year":"2015","unstructured":"Shennar HK, Al-Asmar D, Kaddoura A, Al-Fahoum S. Diagnosis and clinical features of organic acidemias: A hospital-based study in a single center in Damascus, Syria. Qatar Med J. 2015;2015(1):9. https:\/\/doi.org\/10.5339\/qmj.2015.9.","journal-title":"Qatar Med J"},{"issue":"3","key":"6719_CR26","first-page":"258","volume":"90","author":"S Hadj-Taieb","year":"2012","unstructured":"Hadj-Taieb S, Nasrallah F, Hammami MB, Elasmi M, Sanhaji H, Moncef F. &Kaabachi, N. Aminoacidopathies and organic acidurias in Tunisia: a retrospective survey over 23 years. Tunis Med. 2012;90(3):258\u201361.","journal-title":"Tunis Med"},{"issue":"18","key":"6719_CR27","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.clinbiochem.2013.08.009","volume":"46","author":"PE Karam","year":"2013","unstructured":"Karam PE, Habbal MZ, Mikati MA, Zaatari GE, Cortas NK, Daher RT. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience. Clin Biochem. 2013;46(18):1787\u201392. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.08.009.","journal-title":"Clin Biochem"},{"key":"6719_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ymgmr.2018.05.003","volume":"16","author":"N Shibata","year":"2018","unstructured":"Shibata N, Hasegawa Y, Yamada K, Kobayashi H, Purevsuren J, Yang Y, Dung VC, Khanh NN, Verma IC, Bijarnia-Mahay S, Lee DH, Niu DM, Hoffmann GF, Shigematsu Y, Fukao T, Fukuda S, Taketani T&, Yamaguchi S. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening vs. expanded newborn screening. Mol Genet Metab Rep. 2018;16:5\u201310. https:\/\/doi.org\/10.1016\/j.ymgmr.2018.05.003.","journal-title":"Mol Genet Metab Rep"},{"key":"6719_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D, Burlina A, Fowler B, Gr\u00fcnert SC, Gr\u00fcnewald S, Honzik T, Merinero B, P\u00e9rez-Cerd\u00e1 C, Scholl-B\u00fcrgi S, Skovby F, Wijburg F, MacDonald M, Martinelli D, Sass JO, Valayannopoulos V, Chakrapani A. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130. https:\/\/doi.org\/10.1186\/s13023-014-0130-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"6719_CR30","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/petr.12804","volume":"20","author":"R Sakamoto","year":"2016","unstructured":"Sakamoto R, Nakamura K, Kido J, Matsumoto S, Mitsubuchi H, Inomata Y, Endo F. Improvement in the prognosis and development of patients with methylmalonic acidemia after livingdonor liver transplant. Pediatr Transpl. 2016;20(8):1081\u20136. https:\/\/doi.org\/10.1111\/petr.12804.","journal-title":"Pediatr Transpl"},{"key":"6719_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13023-019-1268-1","volume":"14","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Shi Y, Shi Y, Gan LX, Kong YY, Zhu ZJ, Wang HB, Sun LY. .Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report. Orphanet J Rare Dis. 2019;14:139. https:\/\/doi.org\/10.1186\/s13023-019-1268-1.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"6719_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jimd.12183","volume":"43","author":"L Kang","year":"2020","unstructured":"Kang L, Liu Y, Shen M, Liu YI, He R, Song J, Jin J, Li M, Zhang Y, Dong H, Liu X, Yan H, Qin J, Zheng H, Chen Y, Li D, Wei H, Zhang H, Sun L, Zhu Z, Liang D, Yang Y. A study on a cohort of 301 Chinese patients with isolated methylmalonic acidemia. J Inherit Metab Dis. 2020;43(3):409\u201323. https:\/\/doi.org\/10.1002\/jimd.12183.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"6719_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/jimd.12142","volume":"42","author":"PG Tsygankova","year":"2019","unstructured":"Tsygankova PG, Itkis YS, Krylova TD, Kurkina MV, Bychkov IO, Ilyushkina AA, Zabnenkova VV, Mikhaylova SV, Pechatnikova NL, Sheremet NL, Zakharova EY, Zakharova EY. Plasma FGF-21 and GDF\u201015 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders. J Inherit Metab Dis. 2019;42(5):918\u201333. https:\/\/doi.org\/10.1002\/jimd.12142.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"6719_CR34","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/acn3.51104","volume":"7","author":"Y Lin","year":"2020","unstructured":"Lin Y, Ji K, Ma X, Liu S, Li W, Zhao Y, Yan C. Accuracy of FGF-21 and GDF\u201015 for the diagnosis of mitochondrial disorders: A meta\u2010analysis. Ann Clin Transl Neurol. 2020;7(7):1204\u201313. https:\/\/doi.org\/10.1002\/acn3.51104.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"6719_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2021.12.001","volume":"135","author":"LG Riley","year":"2022","unstructured":"Riley LG, Nafisinia M, Menezes MJ, Nambiar R, Williams A, Barnes EH, Selvanathan A, Lichkus K, Bratkovic D, Yaplito-Lee J, Bhattacharya K, Ellaway C, Kava M, Balasubramaniam S, Christodoulou J. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children. Mol Genet Metab. 2022;135(1):63\u201371. https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.001.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"6719_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/dmcn.14086","volume":"61","author":"S Jary","year":"2019","unstructured":"Jary S. The Standardized Infant NeuroDevelopmental Assessment: validation of a new scale. Dev Med Child Neurol. 2019;61(6):623. https:\/\/doi.org\/10.1111\/dmcn.14086.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"6719_CR37","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/dmcn.15871","volume":"66","author":"DM Romeo","year":"2024","unstructured":"Romeo DM, Velli C, Sini F, Pede E, Cicala G, Cowan FM, Ricci D, Brogna C, Mercuri E. Neurological assessment tool for screening infants during the first year after birth: The Brief-Hammersmith Infant Neurological Examination. Dev Med Child Neurol. 2024;66(9):1173\u201380. https:\/\/doi.org\/10.1111\/dmcn.15871.","journal-title":"Dev Med Child Neurol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06719-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06719-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06719-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:30Z","timestamp":1781643510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06719-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6719"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06719-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the declaration of Helsinki for studies involving human participants and was approved by the institutional research ethics committee at Faculty of Medicine, Cairo University (Approval code:#MD-299-2021). Written informed consents to participate and to publish were obtained from parents\/legal guardians of all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}